Previous close | 0.2500 |
Open | 0.3000 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 200.00 |
Expiry date | 2024-04-26 |
Day's range | 0.0100 - 0.9400 |
Contract range | N/A |
Volume | |
Open interest | 115 |
Biogen ( NASDAQ:BIIB ) First Quarter 2024 Results Key Financial Results Revenue: US$2.29b (down 7.0% from 1Q 2023). Net...
It's been a good week for Biogen Inc. ( NASDAQ:BIIB ) shareholders, because the company has just released its latest...
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.